Evaluation of Response to Pain From Skull Pin Fixation in Craniotomies
NCT ID: NCT06811701
Last Updated: 2025-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
120 participants
OBSERVATIONAL
2025-02-28
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does the analysis of blood pressure, heart rate, and brain wave activity indicate the patient's response to skull pin fixation pain during brain surgery? How do the methods used to reduce skull pin fixation pain in brain surgeries affect narcotic opioid consumption? The researchers will monitor the patients' response to skull pin fixation pain during surgery through the analysis of brain wave activity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Scalp Nerve Block on Postoperative Pain, Hemodynamics and Surgical Stress Response in Craniotomy Surgery
NCT06748547
Effects of SCALP Block on Postoperative Analgesia in Craniotomy Surgery
NCT06588751
The Efficacy of Scalp Block in Craniotomy
NCT06951230
Pre-emptive Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Postoperative Pain After Craniotomy
NCT04078139
Opioid-Sparing Multimodal Analgesia Versus Opioid Analgesia for Postoperative Pain After Elective Craniotomy
NCT05474040
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: Scalp group
"This group consists of patients who receive a scalp nerve block for pain management during skull pin fixation."
Scalp nerve block
Patient in this group will receive a scalp nerve block using bupivacaine before skull pin fixation to manage to pain.
Group 2: Opioid Group
"This group consists of patients who receive intravenous opioids for pain management during skull pin fixation."
Opioid Anesthetics
Patient in this group will receive IV opioid for pain management before skull pin fixation
Group 3: Local Anesthetic Group
"This group consists of patients who receive a local anesthetic injection at the pin site before skull pin fixation."
Local Anesthetic Injection
"Patients in this group will receive a local anesthetic (such as lidocaine) injection at the pin site before skull pin fixation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scalp nerve block
Patient in this group will receive a scalp nerve block using bupivacaine before skull pin fixation to manage to pain.
Opioid Anesthetics
Patient in this group will receive IV opioid for pain management before skull pin fixation
Local Anesthetic Injection
"Patients in this group will receive a local anesthetic (such as lidocaine) injection at the pin site before skull pin fixation.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients classified as ASA I-II according to the American Society of Anesthesiologists (ASA) classification.
* Patients scheduled for surgery under general anesthesia.
* Patients who provide written informed consent to participate in the study.
* Patients with normal cognitive function (i.e., no diagnosed dementia or severe cognitive impairment).
* Patients with a preoperative BIS value within the normal range (i.e., no extreme baseline deviations).
Exclusion Criteria
* Patients with neurological disorders (e.g., Parkinson's disease, epilepsy, stroke history).
* Patients with psychiatric disorders (e.g., severe depression, schizophrenia) that may affect pain perception and response.
* Patients with known allergies to local anesthetics or opioids.
* Pregnant or breastfeeding women.
* Patients with contraindications to anesthesia, including but not limited to:
* Severe cardiovascular disease (e.g., uncontrolled hypertension, recent myocardial infarction).
* Severe respiratory disease (e.g., COPD, uncontrolled asthma).
* Patients with any neurological or pharmacological condition that may interfere with BIS-DSA or EEG measurements.
* Patients with preoperative chronic opioid use (≥3 months) due to potential tolerance affecting response to intraoperative analgesia.
* Patients with a history of substance abuse that may alter the BIS response or anesthetic metabolism.
* Patients with significant hearing or communication impairments, preventing them from understanding or responding to preoperative assessments.
* Patients with significant scalp pathology (e.g., infections, scars, large vascular malformations) at the BIS electrode placement site, which may interfere with signal acquisition.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diskapi Teaching and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ceyda Ozhan Caparlar
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ceyda Ozhan Caparlar, MD
Role: PRINCIPAL_INVESTIGATOR
Ankara Etlik City Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AESH-BADEK-2016-1016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.